Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Diabetes Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Diabetes Control

Insulin glargine plus insulin lispro improved glycemic control in type 1 diabetes

In a recent study, researchers in England conducted a study "To compare blood glucose control using insulin glargine + insulin lispro with that on NPH insulin + unmodified human insulin in adults with type 1 diabetes managed with a multiple injection regimen."

S.G. Ashwell and colleagues at the Newcastle Diabetes Center explained, "In this 32-week, five-center, two-way cross-over study, people with type 1 diabetes (n=56, baseline HbA_1c 8.0±0.8%) were randomized to evening insulin glargine + mealtime insulin lispro or to NPH insulin (once-or...

• View Other Issues of Diabetes Week
  
• View Other NewsRx Publications